Trials / Conditions / Plasma Cell Myeloma Refractory
Plasma Cell Myeloma Refractory
3 registered clinical trials studyying Plasma Cell Myeloma Refractory — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adu NCT06356571 | Sanofi | Phase 2 |
| Recruiting | A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With NCT06630806 | Sanofi | Phase 1 |
| Recruiting | Isatuximab in Combination With Novel Agents in RRMM - Master Protocol NCT04643002 | Sanofi | Phase 1 / Phase 2 |